year
111Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 201341-05-1 | ||
EC NO: | |||
Molecular Formula: | C19H30N5O10P | ||
Molecular Weight: | 519.4428 | ||
Specification: | 99% | ||
InChI: | InChI=1/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1 | ||
Product description: Tenofovir disoproxil CAS 201341-05-1 Synonyms: 5-[[(1r)-2-(6-Amino-9h-Purin-9-Yl)-1-Methylethoxy]Methyl]-2,4,6,8-Tetraoxa-5-Phosphanononanedioic Acid Bis(1-Methylethyl) Ester 5-Oxide;9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine;Tenofovir disoproxil;202138-50-9 (1:1 Fumarate salt);Aids080741;Aids-080741;Bis(isopropyloxymethylcarbonyl)pmpa;Bis(poc)pmpa MF: C19H30N5O10P MW: 519.44 |
|||
Uses: | Anti-HBV | ||
Synonyms: | 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine;bis({[(1-methylethoxy)carbonyl]oxy}methyl) {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonate;TD; | ||
Molecular Structure: |